Takatomo Hirouchi

Meguro, 1538515, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Distinct Bronchoalveolar Lavage Cytokine Signature Characterizes Nontuberculous Mycobacterial Pulmonary Disease.

A Distinct Bronchoalveolar Lavage Cytokine Signature Characterizes Nontuberculous Mycobacterial Pulmonary Disease.

Journal: Medical sciences (Basel, Switzerland)

Published: June 04, 2026

High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study.

High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case-Control Study.

Journal: International journal of general medicine

Published: February 16, 2023

Waterproofing Spray-Associated Lung Injury Review: Differences between Cases of Early and Delayed Improvement of Waterproofing Spray-Associated Lung Injury.

Waterproofing Spray-Associated Lung Injury Review: Differences between Cases of Early and Delayed Improvement of Waterproofing Spray-Associated Lung Injury.

Journal: Journal of clinical medicine

Published: February 13, 2023

Effects of Dupilumab for Asthma-chronic Obstructive Pulmonary Disease Overlap.

Effects of Dupilumab for Asthma-chronic Obstructive Pulmonary Disease Overlap.

Journal: Iranian journal of allergy, asthma, and immunology

Published: March 23, 2022

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

Journal: Nature communications

Published: December 14, 2021

DOCK2 is involved in the host genetics and biology of severe COVID-19.

DOCK2 is involved in the host genetics and biology of severe COVID-19.

Journal: Nature

Published: October 26, 2021

Successful treatment of an elderly patient with severe eosinophilic asthma and eosinophilic myocarditis using benralizumab.

Successful treatment of an elderly patient with severe eosinophilic asthma and eosinophilic myocarditis using benralizumab.

Journal: Geriatrics & gerontology international

Published: September 18, 2021

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.

Journal: Infectious diseases and therapy

Published: May 21, 2021

Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid.

Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid.

Journal: Internal medicine (Tokyo, Japan)

Published: January 04, 2021

Clinical Features of 154 COVID-19 Patients and the Parameters for the Effective Detection of Pneumonia at the Time of the Initial Diagnosis in Japan.

Clinical Features of 154 COVID-19 Patients and the Parameters for the Effective Detection of Pneumonia at the Time of the Initial Diagnosis in Japan.

Journal: Internal medicine (Tokyo, Japan)

Published: November 02, 2020

A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful.

A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: August 21, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026